were not classified by currently accepted criteria,3 but Cfetus has probably been responsible for 10 previously reported human abortions. 4 Thermophilic campylobacters, including Cjejuni and C coli, have been identified in 11 previously reported cases,45 but many of these were not investigated with the hippurate hydrolysis test that is required for further identification.
Clinical features of this case are similar to those previously reported, with abortion occurring in the second trimester, and associated with a mild maternal illness consisting of diarrhoea and fever.
Histological examination of the placenta was not included for many of the previously reported cases, but the existing descriptions are all similar, with perivillous fibrin deposition, an inflammatory infiltrate of neutrophil polymorphonuclear leucocytes, and microabscess formation. In sharp contrast to the bovine cases, there has been no evidence of chorioamnionitis in all the cases reported to date. The presence of this feature in this case raises the possibility of ascending infection rather than septicaemic spread, and this may therefore be an alternative route of infection in humans.
The recognition of Campylobacter species as a cause of diarrhoea was delayed because they have fairly exacting cultural requirements and will not grow with the incubation and media regimens that are commonly used. They can, however, be reliably cultured and identified under suitable conditions. This realisation has led to their frequent detection in faecal specimens.
The finding of unexplained villitis with negative bacteriological investigations in spontaneous abortion is not uncommon, and it is possible that some of these cases are in fact due to Campylobacter species.
Abstract
Twenty four primary stromal tumours of the stomach and small intestine were investigated by silver staining of interphase nucleolar organiser regions (AgNORs) in an attempt to obtain an objective criterion for prediction of malignant tumour behaviour. Malignant tumours tended to have higher AgNOR counts than their benign counterparts, but this increase was small and there was some overlap between the two groups. There was a correlation between the mean AgNOR count and the mitotic count. There was no correlation between tumour size and these two measurements. This study suggests that in these stromal tumours the AgNOR count is not a useful independent predictor of malignant behaviour.
Definitive histopathological distinction between benign and malignant stromal tumours of the gut is often difficult. It is widely accepted that the most discriminative criterion in distinguishing these groups is the mitotic count.'2 The ability to predict an individual tumour's behaviour is of great importance in planning the treatment and continuing care of the patient.
It has been proposed that an increased number of actively transcribing nucleolar organiser regions is a marker of malignancy3 and that staining these structures by the AgNOR technique may be useful in the diagnois and assessment of prognosis in some tumours. 4 This study investigated whether the enumeration of AgNORs in stromal tumours of the stomach and small intestine is useful as a diagnostic method to distinguish benign from malignant tumours or if it is an independent predictor of prognosis.
Methods
All 29 surgical resection specimens of stromal tumours of the stomach and small intestine performed at East Birmingham Hospital over a 15 year period were reviewed. Four of these tumours were small and were incidental findings in specimens resected for other pathology. There was insufficient follow up on a fifth tumour which was also less than 1 cm in diameter. The 24 cases with adequate clinical and follow up data were studied further. Seventeen of these tumours were from the stomach and the remaining seven from the small bowel.
The patients' ages varied from 16 to 85 years (mean 62 years). There were 11 men and 13 women. Five of the gastric tumours and two of the small bowel tumours had been originally called malignant on the basis of their histological and clinical features. All of the original sections from these cases were reviewed.
Serial 3 ,um sections were cut from representative blocks of each tumour, and one section was stained with haematoxylin and eosin for assessment ofthe mitotic count. The number of mitoses in 40 high power fields was counted from the most cellular areas of each tumour using a Leitz Dialux 20EB microscope at a magnification of x 400 (1 high power field area = 0-159 mm2). Sections of the tumours were stained with the standard AgNOR technique for nucleolar organiser regions3 and a modified AgNOR method that used polyethylene glycol 20 000 as the colloidal developer. 5 The number of AgNORs in 200 tumour cell nuclei from the most cellular areas of each tumour were counted at a magnification of x 1000.6 The mean number ofAgNORs per nucleus was calculated for each specimen. The mean number of mitoses per 10 high power fields in the benign tumours was 0-71, and in the malignant group, 5 0. The difference in the medians between the two groups was 5 (95% CI 1 to 6). There was overlap between the groups: two of the malignant tumours had mitotic counts in the range that included all of the benign tumours (0 to 2).
AgNOR staining of the tumours with the standard AgNOR technique' resulted in unacceptable non-specific precipitate on the dense stroma often found in these tumours, and this made accurate AgNOR counting impossible in many cases. In contrast, with the modified AgNOR staining method, all tumours gave well defined AgNOR staining with minimal background staining and precipitate. The mean number of AgNORs per nucleus for the benign tumours was 1-48 and for the malignant tumours 3*16 ( figure) . The difference between the medians of the two groups was 1 69 (95% CI 0 71 to 2-77). There was, however, overlap between the two groups: three of the seven malignant tumours had AgNOR counts similar to the range seen in the benign group. When the maximum number of AgNORs in each tumour was considered there was a similar degree of overlap between benign and malignant groups. There was a correlation between the AgNOR count and the mitotic count (r = 0 74, 95% CI 0 48 to 088). Of the four patients who died of malignant disease, all had mitotic counts for 5 to 10 per high power fields. One of these tumours had an AgNOR count within the range shown by the benign tumours. There was no difference in the range of AgNOR counts between gastric and small bowel tumours. No correlation was found between tumour size and the AgNOR or mitotic counts.
Discussion
The malignant tumours tended to have higher AgNOR counts than their benign counterparts, but the difference between these values in the two groups was small and there was a degree of overlap between them. These results are similar to those of Sinn et a17. In contrast to their findings, however, we found that the interphase AgNOR count seemed to correlate with the mitotic count.
In this study the AgNOR count was no more discriminating than the mitotic count in distinguishing benign from malignant stromal tumours. The two parameters are probably related, in keeping with the opinion that the I Beer, Rowlands, Crocker AgNOR counts represent a marker of proliferative activity. 4 Although there are problems and limitations to mitotic counting,8 this method has become widely accepted in the routine assessment of stromal tumours of the gut.2 The mitotic count can be performed more quickly and easily than AgNOR staining and uses routinely available haematoxylin and eosin stained sections. There is also a wider variation in the mitotic count than there is for the AgNOR count. Because there is only a small difference in AgNOR count between benign and malignant tumours, it is unlikely that the technique has any practical use for the diagnosis or prognostication in these neoplasms.
